Correction	O
of	O
dilutional	B:C0472711
anemia	I:C0472711
induces	O
renal	O
dysfunction	I:C3279454
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
:	O
a	O
consequence	O
of	O
microcirculatory	O
alterations	O
?.	O

Correction	O
of	O
dilutional	O
anemia	I:C0472711
induces	O
renal	B:C3279454
dysfunction	I:C3279454
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
:	O
a	O
consequence	O
of	O
microcirculatory	O
alterations	O
?.	O

Correction	O
of	O
dilutional	O
anemia	I:C0472711
induces	O
renal	O
dysfunction	I:C3279454
in	O
diabetic	B:C0011847
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
:	O
a	O
consequence	O
of	O
microcirculatory	O
alterations	O
?.	O

Correction	O
of	O
dilutional	O
anemia	I:C0472711
induces	O
renal	O
dysfunction	I:C3279454
in	O
diabetic	O
patients	O
undergoing	O
coronary	B:C0010055
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
:	O
a	O
consequence	O
of	O
microcirculatory	O
alterations	O
?.	O

Correction	O
of	O
dilutional	O
anemia	I:C0472711
induces	O
renal	O
dysfunction	I:C3279454
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
:	O
a	O
consequence	O
of	O
microcirculatory	B:C0025962
alterations	O
?.	O

In	O
this	O
study	B:C2603343
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	B:C0472711
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	B:C0086252
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	B:C0232804
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	B:C0011847
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	B:C0010055
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

In	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
dilutional	O
anemia	I:C0472711
resulting	O
from	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
and	O
its	O
correction	O
with	O
red	O
blood	I:C0086252
cell	I:C0086252
(	I:C0086252
RBC	I:C0086252
)	I:C0086252
transfusion	I:C0086252
on	O
tissue	O
oxygenation	O
and	O
renal	O
function	I:C0232804
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
(	O
coronary	B:C0010055
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
)	O
.	O

70	O
diabetic	B:C0011847
patients	O
who	O
underwent	O
elective	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	O
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	O
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

70	O
diabetic	O
patients	O
who	O
underwent	O
elective	O
coronary	B:C0010055
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	O
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	O
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

70	O
diabetic	O
patients	O
who	O
underwent	O
elective	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	B:C0518014
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	O
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

70	O
diabetic	O
patients	O
who	O
underwent	O
elective	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	O
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	B:C0007202
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

70	O
diabetic	O
patients	O
who	O
underwent	O
elective	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	O
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	O
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

70	O
diabetic	O
patients	O
who	O
underwent	O
elective	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	O
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	O
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

70	O
diabetic	O
patients	O
who	O
underwent	O
elective	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	O
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	O
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

70	O
diabetic	O
patients	O
who	O
underwent	O
elective	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
and	O
whose	O
hematocrit	O
values	I:C0518014
had	O
been	O
between	O
24	O
-	O
28	O
%	O
at	O
any	O
time	O
during	O
CBP	O
were	O
prospectively	O
randomized	O
and	O
equally	O
allocated	O
to	O
two	O
groups	O
:	O
patients	O
who	O
received	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
group	O
I	O
,	O
n	O
=	O
35	O
)	O
vs.	O
did	O
not	O
receive	O
red	O
blood	I:C0014792
cell	I:C0014792
during	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
(	O
group	O
II	O
,	O
n	O
=	O
35	O
)	O
.	O

Besides	O
routine	O
hemodynamic	B:C0019010
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	B:C0022116
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	B:C0160420
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	B:C3266190
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	B:C3266190
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	B:C1159301
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	B:C1976991
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	B:C1976991
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	B:C0574031
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	B:C0574031
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	B:C0215955
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	B:C0215955
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	B:C3811844
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

Besides	O
routine	O
hemodynamic	O
and	O
biochemical	O
parameters	O
,	O
biomarkers	O
of	O
ischemia	O
and	O
renal	O
injury	I:C0160420
such	O
as	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
(	O
ischemia	O
modified	I:C3266190
albumin	I:C3266190
)	O
,	O
protein	O
oxidation	I:C1159301
parameters	O
[	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
(	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
)	O
,	O
total	O
thiol	I:C0574031
(	O
T	O
-	I:C0574031
SH	I:C0574031
)	O
]	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
(	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
)	O
and	O
estimated	O
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
(	O
estimated	B:C3811844
glomerular	I:C3811844
filtration	I:C3811844
rate	I:C3811844
)	O
were	O
measured	O
in	O
both	O
groups	O
.	O

In	O
group	O
I	O
,	O
T	B:C0574031
-	I:C0574031
SH	I:C0574031
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
and	O
urea	O
levels	I:C0428275
were	O
found	O
to	O
be	O
significantly	O
increased	O
postoperatively	O
compared	O
to	O
preoperative	O
measurements	O
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
group	O
I	O
,	O
T	O
-	I:C0574031
SH	I:C0574031
,	O
neutrophil	B:C0215955
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
and	O
urea	O
levels	I:C0428275
were	O
found	O
to	O
be	O
significantly	O
increased	O
postoperatively	O
compared	O
to	O
preoperative	O
measurements	O
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
group	O
I	O
,	O
T	O
-	I:C0574031
SH	I:C0574031
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
and	O
urea	B:C0428275
levels	I:C0428275
were	O
found	O
to	O
be	O
significantly	O
increased	O
postoperatively	O
compared	O
to	O
preoperative	O
measurements	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Also	O
,	O
postoperatively	O
,	O
neutrophil	B:C0215955
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
,	O
creatinine	O
,	O
aspartate	O
aminotransferase	I:C0004002
and	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
levels	O
were	O
higher	O
in	O
group	O
I	O
than	O
group	O
II	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Also	O
,	O
postoperatively	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
,	O
creatinine	B:C0010294
,	O
aspartate	O
aminotransferase	I:C0004002
and	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
levels	O
were	O
higher	O
in	O
group	O
I	O
than	O
group	O
II	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Also	O
,	O
postoperatively	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
,	O
creatinine	O
,	O
aspartate	B:C0004002
aminotransferase	I:C0004002
and	O
advanced	O
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
levels	O
were	O
higher	O
in	O
group	O
I	O
than	O
group	O
II	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Also	O
,	O
postoperatively	O
,	O
neutrophil	O
gelatinase	I:C0215955
-	I:C0215955
associated	I:C0215955
lipocalin	I:C0215955
,	O
creatinine	O
,	O
aspartate	O
aminotransferase	I:C0004002
and	O
advanced	B:C1976991
oxidative	I:C1976991
protein	I:C1976991
products	I:C1976991
levels	O
were	O
higher	O
in	O
group	O
I	O
than	O
group	O
II	O
(	O
p	O
<	O
0.05	O
)	O
.	O

The	O
correction	O
of	O
anemia	B:C0002871
with	O
RBC	O
transfusion	I:C0086252
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
could	O
increase	O
the	O
risk	O
of	O
renal	O
injury	I:C0160420
.	O

The	O
correction	O
of	O
anemia	O
with	O
RBC	B:C0086252
transfusion	I:C0086252
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
could	O
increase	O
the	O
risk	O
of	O
renal	O
injury	I:C0160420
.	O

The	O
correction	O
of	O
anemia	O
with	O
RBC	O
transfusion	I:C0086252
in	O
diabetic	B:C0011847
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
could	O
increase	O
the	O
risk	O
of	O
renal	O
injury	I:C0160420
.	O

The	O
correction	O
of	O
anemia	O
with	O
RBC	O
transfusion	I:C0086252
in	O
diabetic	O
patients	O
undergoing	O
coronary	B:C0010055
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
could	O
increase	O
the	O
risk	O
of	O
renal	O
injury	I:C0160420
.	O

The	O
correction	O
of	O
anemia	O
with	O
RBC	O
transfusion	I:C0086252
in	O
diabetic	O
patients	O
undergoing	O
coronary	O
artery	I:C0010055
bypass	I:C0010055
grafting	I:C0010055
could	O
increase	O
the	O
risk	O
of	O
renal	B:C0160420
injury	I:C0160420
.	O

Further	O
studies	O
verifying	O
the	O
effects	O
of	O
blood	B:C0005841
transfusions	I:C0005841
at	O
the	O
microcirculatory	O
level	O
are	O
needed	O
to	O
optimize	O
the	O
efficacy	O
of	O
transfusions	O
.	O

Further	O
studies	O
verifying	O
the	O
effects	O
of	O
blood	O
transfusions	I:C0005841
at	O
the	O
microcirculatory	B:C0025962
level	O
are	O
needed	O
to	O
optimize	O
the	O
efficacy	O
of	O
transfusions	O
.	O

Further	O
studies	O
verifying	O
the	O
effects	O
of	O
blood	O
transfusions	I:C0005841
at	O
the	O
microcirculatory	O
level	O
are	O
needed	O
to	O
optimize	O
the	O
efficacy	O
of	O
transfusions	B:C1879316
.	O

